English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Type 1 diabetes occurs in ∼90% of patients with no family history of the disease. The majority of studies seeking to identify at-risk subjects have been conducted in first-degree relatives who comprise just 10% of all cases of type 1 diabetes but may have a 20-fold increased risk for type 1 diabetes (1). Although the peak incidence occurs at adolescence, there are data to suggest that 5–10% of all adults diagnosed with type 2 diabetes may actually have type 1 diabetes (latent autoimmune diabetes in adults [LADA]). If type 1 diabetes is to be prevented, significantly enhanced understanding of both the mechanisms leading to type 1 diabetes and the natural history of the pre-diabetic period is essential.Current evidence suggests that type 1 diabetes results from a complex interaction between type 1 diabetes genetic susceptibility (predominantly HLA Class II associations) and environmental exposure(s) leading to a breakdown of tolerance culminating in β-cell autoimmunity and destruction (2). In the process leading to overt type 1 diabetes, both T and B lymphocytes are activated. B-lymphocyte activation is characterized by the emergence of cytoplasmic islet cell autoantibodies (ICAs) and one or more autoantibodies against the β-cell–specific autoantigen insulin, glutamate decarboxylase, the IA-2 protein tyrosine phosphatase, or the zinc transporter ZnT8 (IAA, GADA, IA-2A, and ZnT8A, respectively). For the most part, IAA, GADA, IA-2A, and ZnT8A have replaced ICA, which is measured using indirect immunofluorescence that requires a subjective evaluation of the fluorescence intensity. The IAA, GADA, IA-2A, and ZnT8A analyses require only small amounts of serum (5–20 μl in most assays) and are thus well suited for large-scale studies comprising both infants and small children. Serum samples can be safely stored at −20°C for years before the measurement of the autoantibodies is undertaken, and the samples usually also tolerate repeated freeze-thaw cycles without …

Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population